פורי-נתול טבליות 50 מג ישראל - עברית - Ministry of Health

פורי-נתול טבליות 50 מג

padagis israel agencies ltd, israel - mercaptopurine - טבליה - mercaptopurine 50 mg - mercaptopurine - mercaptopurine - for the treatment of acute leukemia and also in cases of chronic myelogenous leukemia.

אידסיו ישראל - עברית - Ministry of Health

אידסיו

neopharm (israel)1996 ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

אמג'ויטה ישראל - עברית - Ministry of Health

אמג'ויטה

amgen europe b.v. - adalimumab - תמיסה להזרקה - adalimumab 50 mg / 1 ml - adalimumab

יופלימה ישראל - עברית - Ministry of Health

יופלימה

padagis israel agencies ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg/ml - adalimumab

רמסימה 120 מגמל תת-עורי ישראל - עברית - Ministry of Health

רמסימה 120 מגמל תת-עורי

padagis israel agencies ltd, israel - infliximab - תמיסה להזרקה - infliximab 120 mg/ml - infliximab

יומירה ישראל - עברית - Ministry of Health

יומירה

abbvie biopharmaceuticals ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg / 1 ml - adalimumab

רמיקד ישראל - עברית - Ministry of Health

רמיקד

j-c health care ltd - infliximab - אבקה להכנת תרכיז לאינפוזיה - infliximab 100.0 mg/vial - infliximab - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

ציסטדרופס 3.8 מגמל ישראל - עברית - Ministry of Health

ציסטדרופס 3.8 מגמל

medison pharma ltd - mercaptamine as hydrochloride - תמיסה לעין - mercaptamine as hydrochloride 3.8 mg - mercaptamine

ציסטדרופס 3.8 מגמל ישראל - עברית - Ministry of Health

ציסטדרופס 3.8 מגמל

medison pharma ltd - mercaptamine as hydrochloride - תמיסה לעין - mercaptamine as hydrochloride 3.8 mg - mercaptamine

ציסטגון 150 מג ישראל - עברית - Ministry of Health

ציסטגון 150 מג

medison pharma ltd - cysteamine as bitartrate - קפסולה קשיחה - cysteamine as bitartrate 150 mg - mercaptamine